The present invention relates to compounds having the formula, and pharmaceutically-acceptable salts, prodrugs, solvates, isomers, and/or hydrates thereof, wherein Q is an optionally-substituted phenyl, pyridyl, pyridazinyl, pyrimidinyl, or pyrazinyl ring; R.sub.2 is alkyl or an amino group as defined herein; and Z is optionally-substituted oxadiazolyl or --C(.dbd.O)NR.sub.6, wherein R.sub.6 is lower alkyl or cyclopropyl. The compounds are surprisingly advantageous in preparing pharmaceutical compositions for treating p38 kinase related conditions and/or in methods of treating conditions associated with the activity of p38 kinase in a patient.

 
Web www.patentalert.com

< MicroRNA biomarkers for human breast and lung cancer

> Combination Methods for Preserving Visual Acuity

~ 00475